Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2013

Open Access 01-12-2013 | Research article

Insulin resistance and adipokines serum levels in a caucasian cohort of hiv-positive patients undergoing antiretroviral therapy: a cross sectional study

Authors: Victoria Arama, Catalin Tiliscan, Adrian Streinu-Cercel, Daniela Ion, Raluca Mihailescu, Daniela Munteanu, Adriana Hristea, Stefan Sorin Arama, the SLD-ART study group

Published in: BMC Endocrine Disorders | Issue 1/2013

Login to get access

Abstract

Background

Insulin resistance is frequent in human immunodeficiency virus (HIV) infection and may be related to antiretroviral therapy. Cytokines secreted by adipose tissue (adipokines) are linked to insulin sensitivity. The present study is aimed to assess the prevalence of insulin resistance (IR) and its association with several adipokines, in a non-diabetic Romanian cohort of men and women with HIV-1 infection, undergoing combination antiretroviral therapy (cART).

Methods

A cross-sectional study was conducted in an unselected sample of 89 HIV-1-positive, non-diabetic patients undergoing stable cART for at least 6 months. Metabolic parameters were measured, including fasting plasma insulin, and circulating adiponectin, leptin, resistin, tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) levels. Insulin resistance was estimated by measuring the Quantitative Insulin Sensitivity Check Index (QUICKI), using a cut-off value of 0.33. A linear regression model was fitted to QUICKI to test the association of IR and adipokines levels.

Results

A total of 89 patients (aged 18–65, median: 28 years) including 51 men (57.3%) and 38 women (42.7%) were included in the study. Fifty nine patients (66.3%) were diagnosed with IR based on QUICKI values lower than the cut-off point. IR prevalence was 72.5% in men and 57.6% in women. The presence of the IR was not influenced by either the time of the HIV diagnosis or by the duration of cART. Decreased adiponectin and increased serum triglycerides were associated with increased IR in men (R=0.43, p=0.007). Hyperleptinemia in women was demonstrated to be associated with the presence of IR (R=0.33, p=0.03).

Conclusions

Given the significant prevalence of the IR in our young non-diabetic cohort with HIV infection undergoing antiretroviral therapy reported in our study and the consecutive risk of diabetes and cardiovascular events, we suggest that the IR management should be a central component of HIV-infection therapeutic strategy. As adipokines play major roles in regulating glucose homeostasis with levels varying according to the sex, we suggest that further studies investigating adipokines should base their analyses on gender differences.
Literature
1.
go back to reference Falutz J: Management of Fat Accumulation in Patients with HIV Infection. Curr HIV/AIDS Rep. 2011 Sep, 8 (3): 200-208. 10.1007/s11904-011-0087-3.CrossRefPubMed Falutz J: Management of Fat Accumulation in Patients with HIV Infection. Curr HIV/AIDS Rep. 2011 Sep, 8 (3): 200-208. 10.1007/s11904-011-0087-3.CrossRefPubMed
2.
go back to reference Giralt M, Domingo P, Villarroya F: Adipose tissue biology and HIV-infection. Best Pract Res Clin Endocrinol Metab. 2011 Jun, 25 (3): 487-499. 10.1016/j.beem.2010.12.001.CrossRefPubMed Giralt M, Domingo P, Villarroya F: Adipose tissue biology and HIV-infection. Best Pract Res Clin Endocrinol Metab. 2011 Jun, 25 (3): 487-499. 10.1016/j.beem.2010.12.001.CrossRefPubMed
3.
go back to reference Feeney ER, Mallon PW: Insulin resistance in treated HIV infection. Best Pract Res Clin Endocrinol Metab. 2011 Jun, 25 (3): 443-458. 10.1016/j.beem.2010.11.002.CrossRefPubMed Feeney ER, Mallon PW: Insulin resistance in treated HIV infection. Best Pract Res Clin Endocrinol Metab. 2011 Jun, 25 (3): 443-458. 10.1016/j.beem.2010.11.002.CrossRefPubMed
4.
go back to reference Giannarelli C, Klein RS, Badimon JJ: Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis. 2011, 219 (2): 384-389. 10.1016/j.atherosclerosis.2011.06.003.CrossRefPubMed Giannarelli C, Klein RS, Badimon JJ: Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis. 2011, 219 (2): 384-389. 10.1016/j.atherosclerosis.2011.06.003.CrossRefPubMed
5.
go back to reference Koster JC, Remedi MS, Qiu H, Nichols CG, Hruz PW: HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes. 2003, 52 (7): 1695-1700. 10.2337/diabetes.52.7.1695.CrossRefPubMedPubMedCentral Koster JC, Remedi MS, Qiu H, Nichols CG, Hruz PW: HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes. 2003, 52 (7): 1695-1700. 10.2337/diabetes.52.7.1695.CrossRefPubMedPubMedCentral
6.
go back to reference Hui DY: Effects of HIV protease inhibitor therapy on lipid metabolism. Prog Lipid Res. 2003, 42 (2): 81-92. 10.1016/S0163-7827(02)00046-2.CrossRefPubMed Hui DY: Effects of HIV protease inhibitor therapy on lipid metabolism. Prog Lipid Res. 2003, 42 (2): 81-92. 10.1016/S0163-7827(02)00046-2.CrossRefPubMed
7.
go back to reference Chaparro J, Reeds DN, Wen W, Xueping E, Klein S, Semenkovich CF, Bae KT, Quirk EK, Powderly WG, Yarasheski KE, Li E: Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. Metabolism. 2005, 54 (5): 561-567. 10.1016/j.metabol.2004.08.022.CrossRefPubMedPubMedCentral Chaparro J, Reeds DN, Wen W, Xueping E, Klein S, Semenkovich CF, Bae KT, Quirk EK, Powderly WG, Yarasheski KE, Li E: Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. Metabolism. 2005, 54 (5): 561-567. 10.1016/j.metabol.2004.08.022.CrossRefPubMedPubMedCentral
8.
go back to reference Rabe K, Lehrke M, Parhofer KG, Broedl UC: Adipokines and insulin resistance. Mol Med. 2008, 14 (11–12): 51-741. Rabe K, Lehrke M, Parhofer KG, Broedl UC: Adipokines and insulin resistance. Mol Med. 2008, 14 (11–12): 51-741.
9.
go back to reference Vigouroux C, Maachi M, Nguyên TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP: Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS. 2003, 17: 1503-1511. 10.1097/00002030-200307040-00011.CrossRefPubMed Vigouroux C, Maachi M, Nguyên TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP: Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS. 2003, 17: 1503-1511. 10.1097/00002030-200307040-00011.CrossRefPubMed
10.
go back to reference Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ: Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J Acquir Immune Defic Syndr. 2005, 40 (5): 565-572. 10.1097/01.qai.0000187443.30838.3e.CrossRefPubMed Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ: Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J Acquir Immune Defic Syndr. 2005, 40 (5): 565-572. 10.1097/01.qai.0000187443.30838.3e.CrossRefPubMed
11.
go back to reference World Health Organization: Obesity: Preventing and Managing the Global Epidemic. 2000, Geneva: Technical Report Series No. 894. WHO World Health Organization: Obesity: Preventing and Managing the Global Epidemic. 2000, Geneva: Technical Report Series No. 894. WHO
12.
go back to reference Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85 (7): 2402-2410. 10.1210/jc.85.7.2402.CrossRefPubMed Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85 (7): 2402-2410. 10.1210/jc.85.7.2402.CrossRefPubMed
13.
go back to reference Castaneda-Sceppa C, Bermudez OI, Wanke C, Forrester JE: Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus. J Viral Hepat. 2008 Dec, 15 (12): 878-887. 10.1111/j.1365-2893.2008.01021.x.CrossRefPubMedPubMedCentral Castaneda-Sceppa C, Bermudez OI, Wanke C, Forrester JE: Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus. J Viral Hepat. 2008 Dec, 15 (12): 878-887. 10.1111/j.1365-2893.2008.01021.x.CrossRefPubMedPubMedCentral
14.
go back to reference Jones CY, Wilson IB, Greenberg AS, Shevitz A, Knox TA, Gorbach SL, Spiegelman D, Jacobson DL, Wanke C: Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort. J Acquir Immune Defic Syndr. 2005 Oct 1, 40 (2): 202-211. 10.1097/01.qai.0000165910.89462.2f.CrossRefPubMed Jones CY, Wilson IB, Greenberg AS, Shevitz A, Knox TA, Gorbach SL, Spiegelman D, Jacobson DL, Wanke C: Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort. J Acquir Immune Defic Syndr. 2005 Oct 1, 40 (2): 202-211. 10.1097/01.qai.0000165910.89462.2f.CrossRefPubMed
15.
go back to reference Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R: Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003 Dec, 26 (12): 3320-3325. 10.2337/diacare.26.12.3320.CrossRefPubMed Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R: Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003 Dec, 26 (12): 3320-3325. 10.2337/diacare.26.12.3320.CrossRefPubMed
16.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul, 28 (7): 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul, 28 (7): 412-419. 10.1007/BF00280883.CrossRefPubMed
17.
go back to reference Matti A, Nasta P, Borghi F, Cologni G, Ricci A, Gatti F, Puoti M, Carosi G: Predictors of insulin resistance (IR) in HIV/HCV co-infected patients treated with pegylated interferon alpha 2-a (Peg/IFN) and ribavirin (RBV). 2007, Treatment and Prevention: 4th IAS Conference on HIV Pathogenesis, 22-25. Matti A, Nasta P, Borghi F, Cologni G, Ricci A, Gatti F, Puoti M, Carosi G: Predictors of insulin resistance (IR) in HIV/HCV co-infected patients treated with pegylated interferon alpha 2-a (Peg/IFN) and ribavirin (RBV). 2007, Treatment and Prevention: 4th IAS Conference on HIV Pathogenesis, 22-25.
18.
go back to reference Lebovitz HE: Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001, 109 (Suppl. 2): S135-S148.CrossRefPubMed Lebovitz HE: Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001, 109 (Suppl. 2): S135-S148.CrossRefPubMed
19.
go back to reference DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14: 173-194. 10.2337/diacare.14.3.173.CrossRefPubMed DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14: 173-194. 10.2337/diacare.14.3.173.CrossRefPubMed
20.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed
21.
go back to reference Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrières J: Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care. 2002, 25: 1371-1377. 10.2337/diacare.25.8.1371.CrossRefPubMed Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrières J: Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care. 2002, 25: 1371-1377. 10.2337/diacare.25.8.1371.CrossRefPubMed
22.
go back to reference Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyörälä K: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki policemen study. Arterioscler Thromb Vasc Biol. 2000, 20: 538-544. 10.1161/01.ATV.20.2.538.CrossRefPubMed Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyörälä K: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki policemen study. Arterioscler Thromb Vasc Biol. 2000, 20: 538-544. 10.1161/01.ATV.20.2.538.CrossRefPubMed
23.
go back to reference Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L: Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med. 2002, 19: 470-475. 10.1046/j.1464-5491.2002.00719.x.CrossRefPubMed Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L: Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med. 2002, 19: 470-475. 10.1046/j.1464-5491.2002.00719.x.CrossRefPubMed
24.
go back to reference Hommes MJ, Romijn JA, Endert E, Eeftinck Schattenkerk JK, Sauerwein HP: Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism. 1991 Jun, 40 (6): 651-656. 10.1016/0026-0495(91)90059-6.CrossRefPubMed Hommes MJ, Romijn JA, Endert E, Eeftinck Schattenkerk JK, Sauerwein HP: Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism. 1991 Jun, 40 (6): 651-656. 10.1016/0026-0495(91)90059-6.CrossRefPubMed
25.
go back to reference Walli R, Herfort O, Michl GM, Demant T, Jäger H, Dieterle C, Bogner JR, Landgraf R, Goebel FD: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS. 1998, 12: F167-F173. 10.1097/00002030-199815000-00001.CrossRefPubMed Walli R, Herfort O, Michl GM, Demant T, Jäger H, Dieterle C, Bogner JR, Landgraf R, Goebel FD: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS. 1998, 12: F167-F173. 10.1097/00002030-199815000-00001.CrossRefPubMed
26.
go back to reference Dubé MP, Edmondson-Melançon H, Qian D, Aqeel R, Johnson D, Buchanan TA: Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients. J Acquir Immune Defic Syndr. 2001, 27: 130-134.CrossRefPubMed Dubé MP, Edmondson-Melançon H, Qian D, Aqeel R, Johnson D, Buchanan TA: Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients. J Acquir Immune Defic Syndr. 2001, 27: 130-134.CrossRefPubMed
27.
go back to reference Yan Q, Hruz PW: Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal. J Acquir Immune Defic Syndr. 2005, 40: 398-403. 10.1097/01.qai.0000176654.97392.c7.CrossRefPubMedPubMedCentral Yan Q, Hruz PW: Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal. J Acquir Immune Defic Syndr. 2005, 40: 398-403. 10.1097/01.qai.0000176654.97392.c7.CrossRefPubMedPubMedCentral
28.
go back to reference Florescu D, Kotler DP: Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. Antivir Ther. 2007, 12 (2): 149-162.PubMed Florescu D, Kotler DP: Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. Antivir Ther. 2007, 12 (2): 149-162.PubMed
29.
go back to reference De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A: Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 2008, 31 (6): 9-1224. Epub 2008 Feb 11CrossRef De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A: Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 2008, 31 (6): 9-1224. Epub 2008 Feb 11CrossRef
30.
go back to reference Ziemke F, Mantzoros CS: Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010, 91 (1): 258S-261S. 10.3945/ajcn.2009.28449C.CrossRefPubMed Ziemke F, Mantzoros CS: Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010, 91 (1): 258S-261S. 10.3945/ajcn.2009.28449C.CrossRefPubMed
31.
go back to reference Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46 (7): 79-1369. Epub 2005 Apr 16CrossRef Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46 (7): 79-1369. Epub 2005 Apr 16CrossRef
32.
go back to reference Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002, 277: 25863-25866. 10.1074/jbc.C200251200.CrossRefPubMed Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002, 277: 25863-25866. 10.1074/jbc.C200251200.CrossRefPubMed
33.
go back to reference Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001, 86: 1930-1935. 10.1210/jc.86.5.1930.CrossRefPubMed Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001, 86: 1930-1935. 10.1210/jc.86.5.1930.CrossRefPubMed
34.
go back to reference Deloumeaux J, Maachi M, Sow-Goerger MT, Lamaury I, Velayoudom FL, Cheret A, Batard ML, Muller P, Bastard JP, Chene G, Capeau J, Foucan L: Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: association with insulin resistance and type 2 diabetes. Diabetes Metab. 2011 Apr, 37 (2): 98-104. 10.1016/j.diabet.2010.07.009.CrossRefPubMed Deloumeaux J, Maachi M, Sow-Goerger MT, Lamaury I, Velayoudom FL, Cheret A, Batard ML, Muller P, Bastard JP, Chene G, Capeau J, Foucan L: Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: association with insulin resistance and type 2 diabetes. Diabetes Metab. 2011 Apr, 37 (2): 98-104. 10.1016/j.diabet.2010.07.009.CrossRefPubMed
35.
go back to reference Viganò A, Zuccotti GV, Cerini C, Stucchi S, Puzzovio M, Giacomet V, Mora S: Lipodystrophy, Insulin Resistance, and Adiponectin Concentration in HIV-Infected Children and Adolescents. Curr HIV Res. 2011 Jul, 9 (5): 321-326. 10.2174/157016211797635946.CrossRefPubMed Viganò A, Zuccotti GV, Cerini C, Stucchi S, Puzzovio M, Giacomet V, Mora S: Lipodystrophy, Insulin Resistance, and Adiponectin Concentration in HIV-Infected Children and Adolescents. Curr HIV Res. 2011 Jul, 9 (5): 321-326. 10.2174/157016211797635946.CrossRefPubMed
36.
go back to reference Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002, 103: 137-142. 10.1042/CS20010336.CrossRef Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002, 103: 137-142. 10.1042/CS20010336.CrossRef
37.
go back to reference Mynarcik DC, Combs T, McNurlan MA, Scherer PE, Komaroff E, Gelato MC: Adiponectin and leptin levels in HIV-Infected subjects withinsulin resistance and body fat redistribution. JAIDS. 2002, 31: 514-520. 10.1097/00126334-200212150-00009.PubMed Mynarcik DC, Combs T, McNurlan MA, Scherer PE, Komaroff E, Gelato MC: Adiponectin and leptin levels in HIV-Infected subjects withinsulin resistance and body fat redistribution. JAIDS. 2002, 31: 514-520. 10.1097/00126334-200212150-00009.PubMed
38.
go back to reference Kelesidis T, Kelesidis I, Chou S, Mantzoros CS: Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010 Jan 19, 152 (2): 93-100.CrossRefPubMedPubMedCentral Kelesidis T, Kelesidis I, Chou S, Mantzoros CS: Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010 Jan 19, 152 (2): 93-100.CrossRefPubMedPubMedCentral
39.
go back to reference Azzoni L, Crowther NJ, Firnhaber C: Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women. J Int AIDS Soc. 2010 Sep 7, 13: 33-10.1186/1758-2652-13-33.CrossRefPubMedPubMedCentral Azzoni L, Crowther NJ, Firnhaber C: Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women. J Int AIDS Soc. 2010 Sep 7, 13: 33-10.1186/1758-2652-13-33.CrossRefPubMedPubMedCentral
40.
go back to reference Tao MM, Zhang L, Qiu ZF, Xie J, Han Y, Yu W, Li M, Li TS: Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases. Zhonghua Yi Xue Za Zhi. 2009 Apr 7, 89 (13): 867-871.PubMed Tao MM, Zhang L, Qiu ZF, Xie J, Han Y, Yu W, Li M, Li TS: Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases. Zhonghua Yi Xue Za Zhi. 2009 Apr 7, 89 (13): 867-871.PubMed
41.
go back to reference Nagy GS, Tsiodras S, Martin LD, Avihingsanon A, Gavrila A, Hsu WC, Karchmer AW, Mantzoros CS: Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin. Clin Infect Dis. 2003, 36: 795-802. 10.1086/367859.CrossRefPubMed Nagy GS, Tsiodras S, Martin LD, Avihingsanon A, Gavrila A, Hsu WC, Karchmer AW, Mantzoros CS: Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin. Clin Infect Dis. 2003, 36: 795-802. 10.1086/367859.CrossRefPubMed
Metadata
Title
Insulin resistance and adipokines serum levels in a caucasian cohort of hiv-positive patients undergoing antiretroviral therapy: a cross sectional study
Authors
Victoria Arama
Catalin Tiliscan
Adrian Streinu-Cercel
Daniela Ion
Raluca Mihailescu
Daniela Munteanu
Adriana Hristea
Stefan Sorin Arama
the SLD-ART study group
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2013
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-13-4

Other articles of this Issue 1/2013

BMC Endocrine Disorders 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.